Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(3)

Detailed Status

Completed3

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

completed3100%

Recent Activity

0 active trials
Showing 3 of 3
completednot_applicable

Pilot Clinical Evaluation of the RHEA Vital Sign Vigilance System in Hospital Patients Patients

NCT03269643
completednot_applicable

Pilot Clinical Evaluation of the RHEA Vital Sign Vigilance System in Hospital Patients

NCT03257956
completednot_applicable

Clinical Evaluation of the RHEA Vital Sign Vigilance System in Hospital Patients Patients

NCT03332147

Clinical Trials (3)

Showing 3 of 3 trials
NCT03269643Not Applicable

Pilot Clinical Evaluation of the RHEA Vital Sign Vigilance System in Hospital Patients Patients

Completed
NCT03257956Not Applicable

Pilot Clinical Evaluation of the RHEA Vital Sign Vigilance System in Hospital Patients

Completed
NCT03332147Not Applicable

Clinical Evaluation of the RHEA Vital Sign Vigilance System in Hospital Patients Patients

Completed

All 3 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
3